ARCHIVES

NIH reauthorization to be topic of July 19 hearing.

This article is from The Cancer Letter archive.

Vol. 31 No. 28 | July 15, 2005

Download PDF Visit The Full Archive

Related Articles

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

Eppley Contract Renewed; To Be Recompeted

January 20, 1978

Radiation Oncology To Become Crowded, ACR Warns Physicians

December 15, 1995

UCLA, NYU, Ohio States Must Wait Longer For Comprehensive Status

November 28, 1975

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982